SZSE: 301293 - Sanbo Hospital Management Group Limited

Yield per half year: -57.87%
Dividend yield: 0.00%
Sector: Healthcare

Sanbo Hospital Management Group Limited

80.0080.0070.0070.0060.0060.0050.0050.0040.0040.0030.0030.0020.0020.00Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 69.4 -100% 0 0%
P/S 0 6.51 -100%
P/BV 0 3.96 -100%
P/FCF 0 0 0%
Ev/Ebitda 0 11.85 -100%
Ev/S 0 5.98 -100%
Ev/FCF 0 0 0%
E/P 0 0.0396 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 20.39 -100% 0 0%
ROE 0 11.95 -100%
ROA 0 5.4 -100%
ROIC 0 0 0%
ROS 0 16.23 -100%
ROCE 0 0 0%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0 14.63 -100% 0 0%
Nеt Debt/Ebitda 0 0 0%
Debt/Ratio 0 0 0%
Debt/Equity 0 0 0%
Debt/Net Income 0 3.6 -100%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.83 -100% 0 0%
Number of years of dividend growth 0 1.44 -100%
DSI 0 0.9113 -100%
Average dividend growth 0 10.4 -100%
Average percentage for 5 years 0 1.14 -100%
Average percentage for payments 0 44.8 -100%
Difference from average difference in sector -1.83

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
0 61.43 -100%
Growth impulse Ebitda in 5 years 0 158.62 -100%
Growth impulse Net Income in 5 years 0 66.93 -100%
Growth impulse FCF in 5 years 0 248.41 -100%
Growth impulse EPS in 5 years 0 73.29 -100%
IP Score
2.5/10

Similar companies

Zhejiang Hisoar Pharmaceutical Co., Ltd.

Winning Health Technology Group Co., Ltd.

Yifan Pharmaceutical Co., Ltd.

New Journey Health Technology Group Co.,LTD

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription